Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 70101 - 70125 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	CXCL10	3627	upregulated	Silicon Dioxide results in increased expression of CXCL10 mRNA	4q21.1	A24203 A24205 A24196
Silicon dioxide	Approved	CXCL11	6373	upregulated	Silicon Dioxide analog results in increased expression of CXCL11 mRNA	4q21.1	A24194
Silicon dioxide	Approved	CXCL11	6373	upregulated	Silicon Dioxide results in increased expression of CXCL11 mRNA	4q21.1	A24203
Silicon dioxide	Approved	CXCL12	6387	downregulated	Silicon Dioxide analog results in decreased expression of CXCL12 mRNA	10q11.21	A24195
Silicon dioxide	Approved	CXCL13	10563	downregulated	Silicon Dioxide results in decreased expression of CXCL13 mRNA	4q21.1	A24203
Silicon dioxide	Approved	CXCL2	2920	upregulated	Silicon Dioxide analog results in increased expression of CXCL2 mRNA	4q13.3	A24194 A24195
Silicon dioxide	Approved	CXCL2	2920	upregulated	Silicon Dioxide results in increased expression of CXCL2 mRNA	4q13.3	A24196
Silicon dioxide	Approved	CXCL3	2921	upregulated	Silicon Dioxide analog results in increased expression of CXCL3 mRNA	4q13.3	A24194
Silicon dioxide	Approved	CXCL3	2921	upregulated	Silicon Dioxide results in increased expression of CXCL3 mRNA	4q13.3	A24203 A24197 A24196
Silicon dioxide	Approved	CXCL5	6374	upregulated	Silicon Dioxide analog results in increased expression of CXCL5 mRNA	4q13.3	A24195
Silicon dioxide	Approved	CXCL5	6374	upregulated	Silicon Dioxide results in increased expression of CXCL5 mRNA	4q13.3	A24203 A24205 A24196
Silicon dioxide	Approved	CXCL8	3576	upregulated	Silicon Dioxide analog results in increased expression of CXCL8 mRNA	4q13.3	A24194 A24206 A24195
Silicon dioxide	Approved	CXCL8	3576	upregulated	Silicon Dioxide results in increased expression of CXCL8 mRNA	4q13.3	A24203 A24200 A24197 A24201 A24205 A24196
Silicon dioxide	Approved	CXCL9	4283	upregulated	Silicon Dioxide results in increased expression of CXCL9 mRNA	4q21.1	A24200
Silicon dioxide	Approved	CXCR2	3579	downregulated	Silicon Dioxide results in decreased expression of CXCR2 mRNA	2q35	A24203
Silicon dioxide	Approved	CXCR4	7852	upregulated	Silicon Dioxide results in increased expression of CXCR4 mRNA	2q22.1	A24196
Silicon dioxide	Approved	CXXC4	80319	downregulated	Silicon Dioxide analog results in decreased expression of CXXC4 mRNA	4q24	A24194 A24195
Silicon dioxide	Approved	CXXC5	51523	downregulated	Silicon Dioxide analog results in decreased expression of CXXC5 mRNA	5q31.2	A24195
Silicon dioxide	Approved	CYB5D2	124936	downregulated	Silicon Dioxide analog results in decreased expression of CYB5D2 mRNA	17p13.2	A24195
Silicon dioxide	Approved	CYLD	1540	upregulated	Silicon Dioxide results in increased expression of CYLD mRNA	16q12.1	A24196
Silicon dioxide	Approved	CYP1A1	1543	upregulated	Silicon Dioxide analog results in increased expression of CYP1A1 mRNA	15q24.1	A24194 A24195
Silicon dioxide	Approved	CYP1A1	1543	upregulated	Silicon Dioxide results in increased expression of CYP1A1 mRNA	15q24.1	A24196
Silicon dioxide	Approved	CYP1A2	1544	downregulated	Silicon Dioxide analog results in decreased expression of CYP1A2 mRNA	15q24.1	A24194
Silicon dioxide	Approved	CYP1A2	1544	upregulated	Silicon Dioxide results in increased expression of CYP1A2 mRNA	15q24.1	A24196
Silicon dioxide	Approved	CYP1B1	1545	upregulated	Silicon Dioxide analog results in increased expression of CYP1B1 mRNA	2p22.2	A24194 A24195

Displaying entries 70101 - 70125 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability